sulfonic acid (0.17 mmol). The reaction was performed under nitrogen atmosphere at 80℃ for 3 h.
The resulting product was dissolved in 5 mL CH 2 Cl 2 , filtered, then precipitated by adding 50 mL anhydrous diethyl ether, and finally dried under vacuum to obtain 1.56gmPEG-SA(yield, 74.3%). 1 H NMR (400 MHz, CDCl 3 , δ ppm):3.5-3.8 (m, ~176H, PEGchain -O-CH 2 CH 2 O-), 3 .37(3H, s,CH 3 O-), 2.65(4H, m, -O 2 C-CH 2 -CH 2 -CO 2 H).
Preparation of mPEG-SA-rapamycinconjugate
mPEG-SA-rapamycin was prepared according to the previous report 2 with a minor modification.
Briefly, mPEG-SA(88 mg, 0.042 mmol)was dissolved in 10 mL of anhydrous CH 2 Cl 2 , and then cooled down to 0C.107mg rapamycin (0.12 mmol),30mg DCC (0.15 mmol) and 15mg DMAP were added into it. The resulting solution was stirred at 0Cfor 1 h, then allowing to warm up to room temperature and keep stirringfor 72h. The reaction mixture was filtered and precipitated by anhydrous diethyl ether for two times. The precipitate was dried under vacuumto get 81.1mgmPEG-SA-rapamycin (yield,64.5%). Figure S1A . Thin layer chromatography (TLC, silica gel) analysis of the mPEG-SA-rapamycinconjugate yielded a single peak (silica gel, 10% MeOH in CH 2 Cl 2 ) with a R f value of 0.25, which is completely different from that of the mPEG-SA (1, R f = 0.10), and rapamycin (2, R f = 0.60), confirming that the mPEG-SA-rapamycinconjugate is pure (Figure S1B) 
Water solubility measurement
The water solubility of mPEG-SA-rapamycinwas estimated by simple visual determination. 3 Briefly, a predetermined amount of mPEG-SA-rapamycinor rapamycinsample and 1 mL water were added into a microcentrifuge tube. The tube was placed in a shaking water bath at 25Cwith a shaking speed of 100 rpm. After 24 h, the tubes were observed by the naked eyes.
Preparation ofmPEG-SA-rapamycinmicelles
mPEG-SA-rapamycinmicelles were prepared by a solid dispersion method. 4 Briefly, mPEG-SA-rapamycin(1 mg)wasdissolved in 200 μl acetonitrile to form a mPEG-SA-rapamycin acetonitrile solution. The solution was evaporated under reduced pressureat 25 Cto remove acetonitrile, and then vortexed for 5 min after adding 4 mLwater.The aqueous solution wasfiltered through 0.45μmfilter (Agela Technologies Inc., China) to produce a transparent micelles solution, which was freeze-dried and stored at 4 C for further use.
Characterization of mPEG-SA-rapamycinmicelles

Critical micelle concentration (CMC) determination
The CMC of mPEG-SA-rapamycinmicelles was determined by a steady-state pyrenefluorescence methodusing a Hitachi F-7000 spectrophotometer. 5 The emission wavelength was set at 395 nm and the excitation spectra were recorded from 300 to 350 nm with a bandwidth of 5 nm. The intensity ratio at 337 and 334 nm(I 337 /I 334 ) was used to determine the CMC.
Particle size and zetapotential(ζ) measurements
The zeta potential, particle size and size distribution of mPEG-SA-rapamycin micelles were determined by dynamic light scattering (DLS) using a ZetasizerNano ZS (Malvern Instrument) at 25 •C. Data are displayed as the mean value of at least three measurements ±standard deviation.
Preparation and characterization ofpaclitaxel-loaded mPEG-SA-rapamycinmicelles
Preparationofpaclitaxel-loaded mPEG-SA-rapamycinmicelles
Paclitaxelloaded mPEG-SA-rapamycinmicelleswere prepared by a solid dispersion method. 6 Briefly, paclitaxel (0.9mg) and mPEG-SA-rapamycin (9mg) were dissolved in 100μLacetonitrile to form a paclitaxel and mPEG-SA-rapamycin solution. The solution was evaporated under reduced pressureat 25 Cto remove acetonitrile, and then vortexed for 5 min after adding 10 mLwater.The aqueous solution wasfiltered through a 0.45μm filter (Agela Technologies Inc., China) to produce a transparent micellar solution, which was freeze-dried and stored at 4 C for further use.
Physico-chemical characterization of paclitaxel-loaded mPEG-SA-rapamycinmicelles
The measurements of particle size and size distribution, zeta potential of paclitaxel-loaded mPEG-SA-rapamycinmicelleswere the same as those of mPEG-SA-rapamycinmicelles, described above.
Quantification of encapsulation efficiency and drug loading.The paclitaxel-loaded mPEG-SA-rapamycinmicelles was treated with acetonitrile to get free paclitaxel solution, then filtered with a 0.45μm syringe filter and quantitatively analyzed using high-performance liquid chromatography (HPLC) equipped with a LC-10AVP pump, a SPD-10AVP UV-vis detector (Shimadzu Co., Japan). Each sample solution (30μl) was injected at least three times into a Diamonsil C18 reversed phase column (150×4.60 mm, 5μm) preceded by a C18 guard column (Dikma, China). The mobile phase was a mixture of water and acetonitrile (50:50 v/v). The elution rate was 1.0 mL/min and the paclitaxel detection wavelength was set at 227 nm. The encapsulation efficiency and drug loading content were calculated as below [7] :
Encapsulation efficiency % weight of paclitaxel in micelles weight of feeding paclitaxel 100%
Drug loading content % weight of paclitaxel in micelles weight of micelles 100%
In vitro release test.In order to create pseudo-sink condition, the in vitrodrug release from micelles was determined in 0.01 M PBS(pH 5.0, 7.4) containing1% w/v Tween-80 [8] . 1 mL of the paclitaxel-loaded micelles was filled into a dialysis tube (molecular weight cutoff = 1,000, Snakeskin, Pierce, USA). The dialysis tube was immersed fully in 5mL of the release medium and placed in a shaking water bath at 37°C with a shaking speed of 100 rpm. At predetermined time intervals, the release medium was completely withdrawn and replaced with fresh release medium.
The collected samples were diluted with acetonitrile for HPLC analysis. All measurements were determined in triplicates.
Cell culture
Cell culture experiments were performed in one medium (a RPMI-1640 medium with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin),at 37C under 5% CO 2 atmosphere in an incubator. MCF-7 cells were obtained from Shanghai Institute of Cell Biology, Chinese Academy of Sciences
Cell cycle analysis
MCF-7 cells were seeded at a density of 1.5×105 cells/mL (2 mL medium/well) in 6-well plates and incubated inmediafor 24 h and then treated with rapamycin and mPEG-SA-rapamycin at an equivalent rapamycinconcentration of 20 ng/mL for 24 h at 37 °C. After removal of the media and washing with cold PBS three times, the cells were collected by centrifugation and then fixed with 70% pre-cooled alcohol overnight at 4 °C. Afterwards, the cells were washed to eliminate alcohol and then treated with RNase A (0.1 mg/mL) and PI (0.1 mg/mL) in the dark for 30 min at 37 °C, the cell cycle distribution was analyzed by flow cytometry (FACS Calibur, BD, USA).
In vitrocytotoxicity evaluation
The in vitrocytotoxicity assays were performed. Briefly, MCF-7 cells in their logarithmic growth regime were seeded and incubated in 96-well plates at a density of 5000 cells/well in 200 μL medium for 24 h, then, the culture medium in each well was carefully replaced by 200 μL of fresh medium containing various concentrations of mPEG-SA-rapamycin, the paclitaxel-loaded mPEG-SA-rapamycinmicelles, paclitaxel+rapamycin ( Cells incubated in medium containing 0.1% DMSO were also as controls.
Cellular uptake study
Cells were seeded at a density of 5 × 10 
